98 related articles for article (PubMed ID: 23217386)
21. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
[TBL] [Abstract][Full Text] [Related]
22. A Mek1-Mek2 heterodimer determines the strength and duration of the Erk signal.
Catalanotti F; Reyes G; Jesenberger V; Galabova-Kovacs G; de Matos Simoes R; Carugo O; Baccarini M
Nat Struct Mol Biol; 2009 Mar; 16(3):294-303. PubMed ID: 19219045
[TBL] [Abstract][Full Text] [Related]
23. Major contribution of MEK1 to the activation of ERK1/ERK2 and to the growth of LS174T colon carcinoma cells.
Shama J; Garcia-Medina R; Pouysségur J; Vial E
Biochem Biophys Res Commun; 2008 Aug; 372(4):845-9. PubMed ID: 18533112
[TBL] [Abstract][Full Text] [Related]
24. Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition.
Ohren JF; Chen H; Pavlovsky A; Whitehead C; Zhang E; Kuffa P; Yan C; McConnell P; Spessard C; Banotai C; Mueller WT; Delaney A; Omer C; Sebolt-Leopold J; Dudley DT; Leung IK; Flamme C; Warmus J; Kaufman M; Barrett S; Tecle H; Hasemann CA
Nat Struct Mol Biol; 2004 Dec; 11(12):1192-7. PubMed ID: 15543157
[TBL] [Abstract][Full Text] [Related]
25. Glargine promotes proliferation of breast adenocarcinoma cell line MCF-7 via AKT activation.
Teng JA; Hou RL; Li DL; Yang RP; Qin J
Horm Metab Res; 2011 Jul; 43(8):519-23. PubMed ID: 21773964
[TBL] [Abstract][Full Text] [Related]
26. MEK ablation in MCF-7 cells blocks DNA synthesis induced by serum, but not by estradiol or growth factors.
Estes NR; Thottassery JV; Westbrook L; Kern FG
Int J Oncol; 2006 Dec; 29(6):1573-80. PubMed ID: 17088999
[TBL] [Abstract][Full Text] [Related]
27. Endosomal targeting of MEK2 requires RAF, MEK kinase activity and clathrin-dependent endocytosis.
Galperin E; Sorkin A
Traffic; 2008 Sep; 9(10):1776-90. PubMed ID: 18657070
[TBL] [Abstract][Full Text] [Related]
28. Steady-State Levels of Phosphorylated Mitogen-Activated Protein Kinase Kinase 1/2 Determined by Mortalin/HSPA9 and Protein Phosphatase 1 Alpha in
Wu PK; Hong SK; Park JI
Mol Cell Biol; 2017 Sep; 37(18):. PubMed ID: 28674184
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer.
Dominguez-Escrig JL; Kelly JD; Neal DE; King SM; Davies BR
Clin Cancer Res; 2004 Jul; 10(14):4874-84. PubMed ID: 15269164
[TBL] [Abstract][Full Text] [Related]
30. Fluvastatin attenuates IGF-1-induced ERK1/2 activation and cell proliferation by mevalonic acid depletion in human mesangial cells.
Shibata T; Tamura M; Kabashima N; Serino R; Tokunaga M; Matsumoto M; Miyamoto T; Miyazaki M; Furuno Y; Takeuchi M; Abe H; Okazaki M; Otsuji Y
Life Sci; 2009 May; 84(21-22):725-31. PubMed ID: 19254730
[TBL] [Abstract][Full Text] [Related]
31. Sef downregulation by Ras causes MEK1/2 to become aberrantly nuclear localized leading to polyploidy and neoplastic transformation.
Duhamel S; Hébert J; Gaboury L; Bouchard A; Simon R; Sauter G; Basik M; Meloche S
Cancer Res; 2012 Feb; 72(3):626-35. PubMed ID: 22298595
[TBL] [Abstract][Full Text] [Related]
32. Distinct effects of knocking down MEK1 and MEK2 on replication of herpes simplex virus type 2.
Zhang H; Feng H; Luo L; Zhou Q; Luo Z; Peng Y
Virus Res; 2010 Jun; 150(1-2):22-7. PubMed ID: 20172001
[TBL] [Abstract][Full Text] [Related]
33. Potential anticancer activity of myricetin in human T24 bladder cancer cells both in vitro and in vivo.
Sun F; Zheng XY; Ye J; Wu TT; Wang Jl; Chen W
Nutr Cancer; 2012; 64(4):599-606. PubMed ID: 22482362
[TBL] [Abstract][Full Text] [Related]
34. Purified vitexin compound 1 induces apoptosis through activation of FOXO3a in hepatocellular carcinoma.
Wang JG; Zheng XX; Zeng GY; Zhou YJ; Yuan H
Oncol Rep; 2014 Jan; 31(1):488-96. PubMed ID: 24247909
[TBL] [Abstract][Full Text] [Related]
35. Off-target effects of MEK inhibitors.
Wauson EM; Guerra ML; Barylko B; Albanesi JP; Cobb MH
Biochemistry; 2013 Aug; 52(31):5164-6. PubMed ID: 23848362
[TBL] [Abstract][Full Text] [Related]
36. Mitogen-activated protein kinase (MAPK) signalling pathways in HepG2 cells infected with a virulent strain of Klebsiella pneumoniae.
Wu JH; Hong LC; Tsai YY; Chen HW; Chen WX; Wu TS
Cell Microbiol; 2006 Sep; 8(9):1467-74. PubMed ID: 16922865
[TBL] [Abstract][Full Text] [Related]
37. Ursolic acid-induced AMP-activated protein kinase (AMPK) activation contributes to growth inhibition and apoptosis in human bladder cancer T24 cells.
Zheng QY; Jin FS; Yao C; Zhang T; Zhang GH; Ai X
Biochem Biophys Res Commun; 2012 Mar; 419(4):741-7. PubMed ID: 22387548
[TBL] [Abstract][Full Text] [Related]
38. Short-term interleukin-1(beta) increases the release of secreted APP(alpha) via MEK1/2-dependent and JNK-dependent alpha-secretase cleavage in neuroglioma U251 cells.
Ma G; Chen S; Wang X; Ba M; Yang H; Lu G
J Neurosci Res; 2005 Jun; 80(5):683-92. PubMed ID: 15880353
[TBL] [Abstract][Full Text] [Related]
39. MAP kinase: it's been longer than fifteen minutes.
Sturgill TW
Biochem Biophys Res Commun; 2008 Jun; 371(1):1-4. PubMed ID: 18406346
[TBL] [Abstract][Full Text] [Related]
40. IQGAP1 is a scaffold for mitogen-activated protein kinase signaling.
Roy M; Li Z; Sacks DB
Mol Cell Biol; 2005 Sep; 25(18):7940-52. PubMed ID: 16135787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
